VKH
PRAH

Virtu KCG Holdings’s PRA Health Sciences, Inc. PRAH Stock Holding History

Virtu KCG Holdings’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,117
Closed -$339K – 3619
2016
Q2 		$339K Buy
+8,117
New +$374K 0.01% 1761

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Virtu KCG Holdings's PRAH Position: Q3 2016 in Review

Virtu KCG Holdings sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2016, closing a stake of 8,117 shares — an estimated $339K sold.

Virtu KCG Holdings first reported a position in PRAH in Q2 2016 and held it in 1 quarter. The position peaked at $339K in Q2 2016. 172 funds tracked by Wall St. Rank hold PRAH as of Q3 2016.

  • Virtu KCG Holdings reported no remaining PRA Health Sciences, Inc. position as of Q3 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 8,117 PRA Health Sciences, Inc. shares in Q3 2016, an estimated $339K.
  • Virtu KCG Holdings first reported a position in PRA Health Sciences, Inc. in Q2 2016 and held it in 1 quarter.
  • Virtu KCG Holdings's PRA Health Sciences, Inc. position peaked at $339K in Q2 2016.
  • 172 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2016.

Based on Virtu KCG Holdings's 13F filing for Q3 2016, filed 10 Nov 2016.